GLP-1 Receptors In Human Brain May Help Control Appetite Among T2D Patients, Study Finds.

eports new research presented at the Endocrine Society annual meeting revealed that the “glucagon-like peptide 1 receptors (GLP-1) exist in the brain and help control appetite among patients with type 2 diabetes, providing a possible mechanism by which liraglutide (Victoza) leads to weight loss.” Liraglutide “was associated with a decrease in the attractiveness of fatty, desirable foods as measured by functional MRI (fMRI) studies in a cross-over randomized trial,” conducted by researchers at Harvard Medical School http://www.medpagetoday.com/clinical-context/Diabetes/57143